1 Takahashi JC, Miyamoto S. Moyamoya disease:recent progress and outlook[J]. Neurol Med Chir (Tokyo), 2010, 50:824-832.2 Weinberg DG, Rahme RJ, Aoun SG, et al. Moyamoya disease:Functional and neurocognitive outcomes in the pediatric and adult populations[J]. Neurosurg Focus, 2011, 30:E21.3 Ishii R, Takeuchi S, Ibayashi K, et al. Intelligence in children with moyamoya disease:evaluation after surgical treatments with special reference to changes in cerebral blood flow[J]. Stroke, 1984, 15:873-877.4 Hogan AM, Kirkham FJ, Isaacs EB, et al. Intellectual decline in children with moyamoya and sickle cell anaemia[J]. Dev Med Child Neurol, 2005, 47:824-829.5 Matsushima Y, Aoyagi M, Nariai T, et al. Long-term intelligence outcome of post-encephalo-duro-arteriosynangiosis childhood Moyamoya patients[J]. Clin Neurol Neurosurg, 1997, 99:S147-S150.6 Matsushima Y, Aoyagi M, Koumo Y, et al. Effects of encephalo-duro-arterio- synangiosis on childhood moyamoya patients-swift disappearance of ischemic attacks and maintenance of mental capacity[J]. Neurol Med Chir (Tokyo), 1991, 31:708-714.7 Kuroda S, Houkin K, Ishikawa T, et al. Determinants of intellectual outcome after surgical revascularization in pediat r ic moyamoya disease:a multivar iate analysis[J]. Childs Nerv Syst, 2004, 20:302-308.8 Imaizumi C, Imaizumi T, Osawa M, et al. Serial intelligence test scores in pediatric moyamoya disease[J]. Neuropediatrics, 1999, 30:294-299.9 Ezura M, Yoshimoto T, Fujiwara S, et al. Clinical and angiographic follow-up of childhood onset moyamoya disease[J]. Childs Nerv Syst, 1995, 11:591-594.10 Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis;Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)[J].Neurol Med Chir (Tokyo), 2012, 52:245-266.11 Lee JY, Phi JH, Wang KC, et al. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention[J]. Cerebrovasc Dis,2011, 31:230-237.12 Williams TS, Westmacott R, Dlamini N, et al.Intellectual ability and executive function in pediatric moyamoya vasculopathy[J]. Dev Med Child Neurol,2012, 54:30-37.13 B o w e n M , M a r k s M P , S t e i n b e r g G K .Neuropsychological recover y f rom childhood moyamoya disease[J]. Brain Dev, 1998, 20:119-123.14 Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical ar ticle[J]. J Neurosurg, 2009,111:927-935.15 Patel MD, McKevit t C, Lawrence E. Clinical determinants of long-term quality of life after stroke[J]. Age Ageing, 2007, 36:316-322.16 Su SH, Hai J, Zhang L, et al. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization[J].Eur J Neurol, 2013, 20:1081-1087.17 Calviere L, Catalaa I, Marlats F, et al. Correlation be twe en cog n it ive impa i rment a nd c e r ebr a l hemodynamic disturbances on perfusion magnetic r e sona nc e imag i ng i n Eu rope a n a dult s wit h moyamoya disease[J]. J Neurosurg, 2010, 113:753-759.18 Festa JR, Schwmz LR, Pliskin N, et al. Neurocognitive dysfunction in adult moyamoya disease[J]. J Neurol,2010, 257:806-815.19 Karzmark P, Zeifert PD, Tan S, et al. Effect of moyamoya disease on neuropsychological functioning in adults[J]. Neurosurgery, 2008, 62:1048-1052.20 Karzmark P, Zeifert PD, Bell-Stephens TE, et al.Neurocognitive impairment in adults with moyamoya disease without stroke[J]. Neurosurgery, 2012,70:634-638.21 J e f f e r s o n AL , Gl o s s e r G, De t r e JA, e t a l .Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome[J]. AJNR Am J Neuroradiol, 2006, 27:98-100.22 Calviere L, Ssi Yan Kai G, Catalaa I, et al. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter[J]. J Neurol Neurosurg Psychiatry, 201283:591-593.23 Nakamizo A, Kik kawa Y, Hiwat ashi A, et al.Executive function and diffusion in frontal white matter of adults with moyamoya disease[EB/OL].(2013-04-22)[2013-08-15], http://www.strokejournal.org/article/S1052-3057(13)00104-3/abstract.24 Mogensen MA, Karzmark P, Zeifer t PD, et al.Neuroradiologic correlates of cognitive impairment in adult Moyamoya disease[J]. AJNR Am J Neuroradiol,2012, 33:721-725.25 Choi JU, Kim DS, Kim EY, et al. Natural history of moyamoya disease:comparison of activity of daily living in surgery and non surgery groups[J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2):S11-S18. 26 Hou kin K, Kuroda S, Nakayama N. Cerebr al revascularization for moyamoya disease in children[J]. Neurosurg Clin N Am, 2001, 12:575-584.27 Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis[J]. J Neurosurg, 2004, 100:142-149.28 Ikezaki K, Matsushima T, Kuwabara Y, et al. Cerebral circulation and oxygen metabolism in childhood Moyamoya disease:a perioperative positron emission tomography study[J]. J Neurosurg, 1994, 81:843-850.29 Touho H, Karasawa J, Ohnishi H, et al. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease[J].Stroke, 1996, 27:282-289.30 Hsu YH, Kuo MF, Hu a MS, e t a l. Sele c t ive neuropsychological impairments and related clinical factors in children with moyamoya disease of the transient ischemic attack type[J]. Childs Nerv Syst,2013 Sep 5. [Epub ahead of print].31 Calviere L, Catalaa I, Marlats F, et al. Improvement in cognitive function and cerebral perfusion after bur hole surgery in an adult with moyamoya disease. Case report[J]. J Neurosurg, 2011, 115:347-349.32 雷宇, 倪伟, 江汉强, 等. 烟雾病与认知损害[J]. 国际脑血管病杂志, 2013, 21:69-73.33 段炼. 烟雾病[J]. 中国卒中杂志, 2013, 8:557. |